Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine

Historical observation

20182026

Universe›Health Care›Pharmaceuticals›Pharmaceuticals

1 · Sector

Weight and 12M allocation change

Consumer Discretionary11.6%+3.82 pp Energy4.1%+1.64 pp Health Care17.5%+1.01 pp Consumer Staples7.7%+0.70 pp Utilities3.4%+0.36 pp Real Estate3.1%-0.10 pp Materials2.9%-0.29 pp Industrials9.8%-0.41 pp Communication Services3.3%-0.64 pp Financials12.1%-2.06 pp Information Technology24.5%-4.05 pp

2 · Industry

Inside Health Care

Pharmaceuticals5.55%+0.91 pp Managed Health Care2.73%+0.59 pp Health Care Equipment2.90%-0.54 pp Life Sciences Tools & Services1.91%-0.39 pp Biotechnology2.73%+0.38 pp Health Care Supplies0.13%-0.16 pp Health Care Distributors0.42%+0.15 pp Health Care Services0.93%+0.12 pp Health Care Facilities0.22%-0.05 pp Health Care Technology0.00%+0.00 pp

3 · Sub-industry

Inside Pharmaceuticals

Pharmaceuticals5.55%+0.911 pp

Concentrated

Most of this industry's gains came from a few companies.

View all contributions →

Pharmaceuticals · weight

5.55%

Industry change · 12M

+0.91 pp

Pharmaceuticals · contribution

+0.911 pp

Company participation

43%

of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Oct 2022 · sorted by absolute contribution to 12-month change

Company	Country	Market cap	Universe weight	3M contribution	12M contribution	12M price return	Above 6M weight average
Lilly (Eli) → LLY	United States	$344.0bn	1.221%	+0.144 pp	+0.407 pp	+44.1%	Yes
Johnson & Johnson → JNJ	United States	$454.8bn	1.614%	+0.037 pp	+0.182 pp	+9.6%	No
Merck & Co. → MRK	United States	$256.4bn	0.910%	+0.133 pp	+0.165 pp	+19.0%	Yes
Bristol Myers Squibb → BMY	United States	$164.7bn	0.585%	+0.043 pp	+0.152 pp	+36.8%	Yes
Pfizer → PFE	United States	$261.3bn	0.927%	-0.047 pp	+0.108 pp	+9.9%	No
Zoetis → ZTS	United States	$70.6bn	0.250%	-0.045 pp	-0.092 pp	-29.7%	No
Viatris → VTRS	United States	$12.3bn	0.044%	+0.003 pp	-0.010 pp	-21.1%	No

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.